Summary | |
---|---|
Symbol | ARPP21 |
Name | cAMP-regulated phosphoprotein, 21kDa |
Aliases | ARPP-21; TARPP; R3HDM3; R3H domain containing 3; RCS; cyclic AMP-regulated phosphoprotein, 21 kD; thymocyte ...... |
Chromosomal Location | 3p24.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Cytoplasm |
Domain |
PF01424 R3H domain PF12752 SUZ domain |
Function |
Isoform 2 may act as a competitive inhibitor of calmodulin-dependent enzymes such as calcineurin in neurons. |
Biological Process |
GO:0009266 response to temperature stimulus GO:0009408 response to heat GO:0034605 cellular response to heat |
Molecular Function |
GO:0005516 calmodulin binding |
Cellular Component | - |
KEGG | - |
Reactome | - |
Summary | |
---|---|
Symbol | ARPP21 |
Name | cAMP-regulated phosphoprotein, 21kDa |
Aliases | ARPP-21; TARPP; R3HDM3; R3H domain containing 3; RCS; cyclic AMP-regulated phosphoprotein, 21 kD; thymocyte ...... |
Chromosomal Location | 3p24.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between ARPP21 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | ARPP21 |
Name | cAMP-regulated phosphoprotein, 21kDa |
Aliases | ARPP-21; TARPP; R3HDM3; R3H domain containing 3; RCS; cyclic AMP-regulated phosphoprotein, 21 kD; thymocyte ...... |
Chromosomal Location | 3p24.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of ARPP21 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | ARPP21 |
Name | cAMP-regulated phosphoprotein, 21kDa |
Aliases | ARPP-21; TARPP; R3HDM3; R3H domain containing 3; RCS; cyclic AMP-regulated phosphoprotein, 21 kD; thymocyte ...... |
Chromosomal Location | 3p24.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of ARPP21 in various data sets.
|
Points in the above scatter plot represent the mutation difference of ARPP21 in various data sets.
|
Summary | |
---|---|
Symbol | ARPP21 |
Name | cAMP-regulated phosphoprotein, 21kDa |
Aliases | ARPP-21; TARPP; R3HDM3; R3H domain containing 3; RCS; cyclic AMP-regulated phosphoprotein, 21 kD; thymocyte ...... |
Chromosomal Location | 3p24.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of ARPP21. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | ARPP21 |
Name | cAMP-regulated phosphoprotein, 21kDa |
Aliases | ARPP-21; TARPP; R3HDM3; R3H domain containing 3; RCS; cyclic AMP-regulated phosphoprotein, 21 kD; thymocyte ...... |
Chromosomal Location | 3p24.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of ARPP21. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by ARPP21. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | ARPP21 |
Name | cAMP-regulated phosphoprotein, 21kDa |
Aliases | ARPP-21; TARPP; R3HDM3; R3H domain containing 3; RCS; cyclic AMP-regulated phosphoprotein, 21 kD; thymocyte ...... |
Chromosomal Location | 3p24.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of ARPP21. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | ARPP21 |
Name | cAMP-regulated phosphoprotein, 21kDa |
Aliases | ARPP-21; TARPP; R3HDM3; R3H domain containing 3; RCS; cyclic AMP-regulated phosphoprotein, 21 kD; thymocyte ...... |
Chromosomal Location | 3p24.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of ARPP21 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | ARPP21 |
Name | cAMP-regulated phosphoprotein, 21kDa |
Aliases | ARPP-21; TARPP; R3HDM3; R3H domain containing 3; RCS; cyclic AMP-regulated phosphoprotein, 21 kD; thymocyte ...... |
Chromosomal Location | 3p24.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between ARPP21 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | ARPP21 |
Name | cAMP-regulated phosphoprotein, 21kDa |
Aliases | ARPP-21; TARPP; R3HDM3; R3H domain containing 3; RCS; cyclic AMP-regulated phosphoprotein, 21 kD; thymocyte ...... |
Chromosomal Location | 3p24.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting ARPP21 collected from DrugBank database. |
There is no record. |